Source: Dementia & Neuropsuchologia. Unidade: FM
Subjects: ENSAIO CLÍNICO, DEMÊNCIA, AMILOIDOSE
ABNT
FORLENZA, Orestes Vicente e BARBOSA, Breno José Alencar Pires. What are the reasons for the repeated failures of clinical trials with anti-amyloid drugs for AD treatment? [Editorial]. Dementia & Neuropsuchologia. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/86037. Acesso em: 28 jan. 2026. , 2025APA
Forlenza, O. V., & Barbosa, B. J. A. P. (2025). What are the reasons for the repeated failures of clinical trials with anti-amyloid drugs for AD treatment? [Editorial]. Dementia & Neuropsuchologia. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://observatorio.fm.usp.br/handle/OPI/86037NLM
Forlenza OV, Barbosa BJAP. What are the reasons for the repeated failures of clinical trials with anti-amyloid drugs for AD treatment? [Editorial] [Internet]. Dementia & Neuropsuchologia. 2025 ; 19 e2025E001.[citado 2026 jan. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/86037Vancouver
Forlenza OV, Barbosa BJAP. What are the reasons for the repeated failures of clinical trials with anti-amyloid drugs for AD treatment? [Editorial] [Internet]. Dementia & Neuropsuchologia. 2025 ; 19 e2025E001.[citado 2026 jan. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/86037

